Clinical Trial: Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Brief Summary: Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

Detailed Summary:
Sponsor: Stanford University

Current Primary Outcome: Response: Globe salvage rate (Eyes saved/Eyes treated). This will be determined by clinical ocular examination. [ Time Frame: Follow-up will be performed for one year from treatment date. ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Stanford University

Dates:
Date Received: March 4, 2010
Date Started: September 2010
Date Completion: March 2012
Last Updated: May 10, 2012
Last Verified: May 2012